RECURSION PHARMACEUTICALS, INC.

By person

22 insiders · 461 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Mubadala Investment Co PJSC entity

10% owner

$62.90M (28)

—

+$62.90M

21,726,844

$76.43M

+1,195%

Gibson Christopher

Director

—

$39.44M (226) scheduled

−$39.44M

9,381,826

$33.00M

+9.2%

Borgeson Blake

Director

—

$10.39M (72) scheduled

−$10.39M

6,158,287

$21.66M

−8.9%

Secora Michael

Chief Financial Officer

—

$6.40M (39) scheduled

−$6.40M

1,487,694

$5.23M

+285.5%

Virani Shafique

Chief Business Officer

—

$4.21M (25) scheduled

−$4.21M

136,748

$481.02K

+502.7%

Marriott Tina

President and COO

—

$1.89M (34) scheduled

−$1.89M

506,852

$1.78M

—

Lux Ventures IV, L.P. entity

Former 10% Owner

$1.80M (1)

—

+$1.80M

30,308,614

$106.61M

+75.2%

Burrell Terry-Ann

Director

—

$1.41M (5)

−$1.41M

71,254

$250.64K

−43.7%

Li Dean Y

Director

—

$1.11M (6)

−$1.11M

6,916,377

$24.33M

−5.9%

Khan Najat

CEO and President

—

$1.01M (5) scheduled

−$1.01M

2,072,890

$7.29M

—

Dar Zavain

Director

—

$181.27K (1) scheduled

−$181.27K

240,764

$846.91K

+277.5%

Taylor Ben R

Chief Financial Officer

—

$157.70K (3) scheduled

−$157.70K

1,071,462

$3.77M

+115.8%

Bumpus Namandje

Director

—

$28.13K (2) scheduled

−$28.13K

127,632

$448.96K

—

Bogue Zachary

Director

—

3,736,341

$13.14M

—

Data Collective IV, L.P.

10% owner

—

3,726,963

$13.11M

—

Hallett David

Chief Scientific Officer

—

1,043,837

$3.67M

+75.7%

Mauro David J

Chief Medical Officer

—

225,429

$792.97K

—

Michor Franziska

Director

—

215,477

$757.96K

—

HERSHBERG ROBERT

Director

—

162,156

$570.40K

—

Sun Elaine D

Director

—

135,981

$478.33K

—

Doyle Ramona

Chief Medical Officer

—

121,110

$426.02K

+8,626%

CHAVEZ R. MARTIN

Director

—

60,078

$211.33K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Khan Najat

18 Aug 2025

Chief R&D Commercial Officer

Sell

36,599

$5.52

$202.17K

Borgeson Blake

14 Nov 2023

Director

Sell

8,885

$6.32

$56.15K

Borgeson Blake

31 Oct 2023

Director

Sell

8,885

$5.27

$46.86K

Borgeson Blake

17 Oct 2023

Director

Sell

8,885

$6.58

$58.48K

Borgeson Blake

3 Oct 2023

Director

Sell

8,885

$7.29

$64.78K

Borgeson Blake

19 Sep 2023

Director

Sell

8,885

$8.36

$74.28K

Borgeson Blake

5 Sep 2023

Director

Sell

8,885

$8.79

$78.14K

Borgeson Blake

22 Aug 2023

Director

Sell

8,885

$8.91

$79.18K

Borgeson Blake

8 Aug 2023

Director

Sell

3,272

$11.75

$38.44K

Borgeson Blake

8 Aug 2023

Director

Sell

14,498

$11.03

$159.85K

Borgeson Blake

25 Jul 2023

Director

Sell

18,719

$14.61

$273.46K

Burrell Terry-Ann

13 Jul 2023

Director

Sell

8,275

$12.59

$104.14K

Burrell Terry-Ann

12 Jul 2023

Director

Sell

3,157

$14.08

$44.46K

Burrell Terry-Ann

12 Jul 2023

Director

Sell

3,195

$13.18

$42.12K

Burrell Terry-Ann

12 Jul 2023

Director

Sell

78,071

$12.15

$948.29K

Burrell Terry-Ann

12 Jul 2023

Director

Sell

24,302

$11.25

$273.40K

Borgeson Blake

11 Jul 2023

Director

Sell

8,885

$6.89

$61.19K

Borgeson Blake

27 Jun 2023

Director

Sell

8,885

$7.39

$65.64K

Borgeson Blake

13 Jun 2023

Director

Sell

15,485

$9.98

$154.51K

Borgeson Blake

30 May 2023

Director

Sell

8,885

$8.79

$78.13K

Borgeson Blake

16 May 2023

Director

Sell

8,885

$5.09

$45.24K

Borgeson Blake

18 Apr 2023

Director

Sell

8,885

$5.93

$52.73K

Gibson Christopher

6 Apr 2023

Chief Executive Officer

Sell

40,000

$6.64

$265.67K

Borgeson Blake

4 Apr 2023

Director

Sell

8,885

$6.53

$57.99K

Showing 250 of 461 transactions. The figures above use every one of them.

RECURSION PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out